Kerala Ayurveda Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 ,inter alia, to consider and approve the quarterly results for ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kerala Ayurveda Limited has informed BSE that its Board of Directors will meet on 12th February 2026. The Board will consider and approve the unaudited standalone and consolidated financial results for the quarter and nine months ended 31st December 2025 (Q3FY26). Additionally, the Board will evaluate a proposal for a preferential issue of equity shares, to be done in one or more tranches, subject to regulatory approvals. The company also plans to convene an Extraordinary General Meeting (EGM) to seek shareholder approval for this preferential issue. The trading window for insiders has been closed since 31st December 2025 and will reopen 48 hours after the results are announced.
Retail investors should watch for two key events: (1) the Q3FY26 earnings release on 12th February, which will reveal the company's quarterly performance, and (2) a proposed equity dilution via preferential allotment, which could expand the share count and dilute existing shareholders' stakes depending on the issue price and size.